Informações:
Falhas:
ID
34331
Descrição
A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.; ODM derived from: https://clinicaltrials.gov/show/NCT01088659
Link
https://clinicaltrials.gov/show/NCT01088659
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis D, Chronic NCT01088659
Eligibility Hepatitis D, Chronic NCT01088659
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis D, Chronic NCT01088659
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
adult patients, >/=18 years of age
boolean
ID.2
Item
chronic hepatitis d
boolean
ID.3
Item
positive for hbsag >/=6 months, for anti-hdv >/=3 months and for hdv-rna at screening
boolean
ID.4
Item
negative pregnancy test; fertile males and women of childbearing age should use two reliable forms of contraception throughout study
boolean
ID.5
Item
antiviral therapy for chronic hepatitis d within the previous 6 months
boolean
ID.6
Item
previous therapy with pegylated interferon alfa
boolean
ID.7
Item
treatment with conventional interferon alfa for >12 months
boolean
ID.8
Item
hepatitis a or c, or hiv infection
boolean
ID.9
Item
decompensated liver disease (childs b-c)
boolean
ID.10
Item
history or evidence of medical condition associated with chronic liver disease
boolean